IP Library Granted Patent US 11,754,753
Granted Patent B2
US 11,754,753 · App. 17/228,748 · Granted Sep 12, 2023

Antioxidant contact lens

Inventors: Inna Maltseva (San Francisco, CA); Nancy J. Keir (Pleasanton, CA); Andrew Luk (Pleasanton, CA); Victoria Rogers (Pleasanton, CA)
Assignee: COOPERVISION INTERNATIONAL LIMITED
G02B1/043A45C11/005A61K9/0051A61K31/355C08J3/075C08K5/1545C08J2333/26C08J2383/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,754,753
App. No.
17/228,748
Granted
Sep 12, 2023
Kind
B2
Abstract

A contact lens having antioxidant properties is described as well as methods of manufacturing the same. The contact lens can be present in a sealed contact lens package. The seal contact lens package can include at least a) a plastic base member having a cavity; b) a contact lens packaging solution in the cavity; c) a sterile, unworn contact lens immersed in the contact lens packaging solution in the cavity; and d) a cover that forms a liquid-tight seal with the plastic base member. As an example, the unworn contact lens is a silicone hydrogel contact lens having present therein vitamin E. The vitamin E is non-releasable from the unworn contact lens and the contact lens packaging solution has less than 1 ppm of vitamin E present. The vitamin E is trapped, embedded, absorbed, or non-covalently attached in the unworn contact lens.

Claims (10)

1. An unworn antioxidant contact lens immersed in a packaging solution and sterilely sealed in a package, said contact lens comprising a silicone hydrogel and amount of vitamin E embedded within the silicone hydrogel effective to provide at least a 50% reduction in lipid peroxidation relative to a control contact lens lacking the vitamin E when measured in a TBARS assay, wherein the antioxidant contact lens is free of a bioactive agent having a release profile attenuated by the vitamin E.

2. An unworn antioxidant contact lens immersed in a packaging solution and sterilely sealed in a package, said contact lens comprising a silicone hydrogel and amount of vitamin E embedded within the silicone hydrogel effective to provide at least a 50% reduction in lipid peroxidation relative to a control contact lens lacking the vitamin E when measured in a TBARS assay, wherein the antioxidant contact lens has (a) an ophthalmically-acceptable surface wettability in the absence of a post curing surface treatment and (b) an advancing contact angle that is no more than 10° greater than the control lens.

3. An unworn antioxidant contact lens immersed in a packaging solution and sterilely sealed in a package, said contact lens comprising a silicone hydrogel and 10 μg to 1000 μg of vitamin E embedded in the silicone hydrogel, wherein the antioxidant contact lens (a) has a heat stability that is no greater than a control contact lens lacking the vitamin E and (b) is free of a bioactive agent having a release profile attenuated by the vitamin E.

4. The unworn antioxidant contact lens of claim 1 , wherein the amount of vitamin E is 10 μg to 1000 μg per 25 mg of the antioxidant contact lens when fully hydrated.

5. The unworn antioxidant contact lens of claim 1 having a % equilibrium water content (% EWC) that is no less than 5% that of the control lens.

6. The unworn antioxidant contact lens of claim 1 having between 40% to 60% EWC.

7. The unworn antioxidant contact lens of claim 1 having a lens diameter within ±0.2 mm that of the control lens.

8. The unworn antioxidant contact lens of claim 1 having an advancing contact angle that is no more than 5° greater than the control lens.

9. The unworn antioxidant contact lens of claim 1 wherein the reduction in lipid peroxidation is at least 80%.

10. The unworn antioxidant contact lens of claim 1 , wherein the amount of vitamin E is effective to reduce generation of reactive oxygen species (ROS) from human corneal epithelial cells (HCECs) contacted in vitro with H 2 O 2 relative to the control contact lens when measured in an HCEC viability assay.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2021
From: MALTSEVA, INNA; KEIR, NANCY J.; LUK, ANDREW; ROGERS, VICTORIA
To: COOPERVISION, INC.
Reel/Frame 057257/0973 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2021
From: COOPERVISION, INC.
To: COOPERVISION INTERNATIONAL LIMITED
Reel/Frame 057258/0032 →